Anti-platelet Therapy Terminated Phase 4 Trials for Acetylsalicylic acid (DB00945)

Also known as: Antiplatelet Therapy

IndicationStatusPhase
DBCOND0058194 (Anti-platelet Therapy)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03224923A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)Treatment